Adesina urges African entrepreneurs to invest in anti-malaria drugs
Summary
At least 79% of the drugs consumed on the continent are imported from India and China.
The President of the African Development Bank, Akinwumi Adesina, has advised on the local manufacturing of low-cost generic medicines to facilitate access to malaria treatment in Africa.
Adesina spoke on Sunday at the African Leaders Malaria Alliance (ALMA) work luncheon on the sidelines of the African Union Summit in Addis Ababa, Ethiopia.
Malaria strains national economies and impoverishes households, Adesina said in his statement, adding that the economic impact of the tropical disease is estimated to cost Africa $12 billion every year, impacting some nations’ gross domestic product by as much as 5-6%.
To facilitate access to treatment to as many people as possible on the continent, ownership by African pharmaceutical entrepreneurs of the local production of low-cost generic anti-malarial drugs is imperative, President Adesina said.
Available statistics has it that at least 79% of the drugs consumed on the continent are imported from India and China. The local manufacture of anti-malaria medicines would make them affordable to most Africans families.
“African entrepreneurs – especially those already active in the pharmaceutical industry – should be able to reduce this startling trade deficit by investing in local manufacturing of generic medicines,” Adesina said. “The size of Africa’s pharmaceutical market could grow from $30 billion in 2016 to $40 billion in 2020, given the large proportion of Africans buying malaria medicines and treatments.”
ALMA is a coalition of 49 African Heads of State and Government established in 2009 and working across country and regional borders to eliminate malaria by 2030. It was inspired by the African Union vision of an Africa free of malaria and guided by the World Health Organization’s Global Technical Strategy for Malaria 2016-2030.
Related
-
Malaria To Zero: Access Bank's paradigm for anti-malaria
Strategies for eradicating malaria in Nigeria must focus on removing malaria parasites entirely from the population.
-
Coalition writes Buhari on investment in healthcare
The group said healthcare is the foundation of national security, economic growth and recovery plan.
-
Access Bank wins Nigerian Healthcare Excellence Award 2019
Through various financing schemes and health initiatives, Access Bank is at the forefront of innovation and support for ...
Sustainable Development Section Sponsor
-
Access Bank Plc ...Financing the future
Most Popular
- Solar mini-grid opportunities for rural electrification in Nigeria
- Dangote-led health coalition appoints new CEO
- AfDB approves €188 million loan for Kenya to fight COVID-19
- Access Bank drives financial e-learning for kids amid COVID-19
- Kenyan healthtech startup gets investment from MIT venture fund
- Covid-19 response must include provision of food to the vulnerable
- AfDB’s new 5-year strategy for Nigeria to tackle Covid-19 economic shocks
